BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 32371595)

  • 1. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune Profiling To Predict Outcome of Clostridioides difficile Infection.
    Abhyankar MM; Ma JZ; Scully KW; Nafziger AJ; Frisbee AL; Saleh MM; Madden GR; Hays AR; Poulter M; Petri WA
    mBio; 2020 May; 11(3):. PubMed ID: 32457246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection.
    Limsrivilai J; Rao K; Stidham RW; Govani SM; Waljee AK; Reinink A; Johnson L; Briggs E; Higgins PDR
    Dig Dis Sci; 2018 Jul; 63(7):1801-1810. PubMed ID: 29644517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal host biomarkers predicting severity of Clostridioides difficile infection.
    Golizeh M; Winter K; Roussel L; Landekic M; Langelier M; Loo VG; Ndao M; Vinh DC
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease.
    Abdehagh M; Azimirad M; Houri H; Nadalian B; Azimirad F; Olfatifar M; Nasir Shoeibi OK; Yadegar A; Shahrokh S; Mahdavi Roshan M; Asadzadeh Aghdaei H; Zali MR
    BMC Infect Dis; 2021 Oct; 21(1):1103. PubMed ID: 34702217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk prediction for 30-day mortality among patients with
    Chiang HY; Huang HC; Chung CW; Yeh YC; Chen YC; Tien N; Lin HS; Ho MW; Kuo CC
    Antimicrob Resist Infect Control; 2019; 8():175. PubMed ID: 31749963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.
    Perry DA; Shirley D; Micic D; Patel PC; Putler R; Menon A; Young VB; Rao K
    Clin Infect Dis; 2022 Jun; 74(11):2028-2035. PubMed ID: 34459885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modest Clostridiodes difficile infection prediction using machine learning models in a tertiary care hospital.
    Marra AR; Alzunitan M; Abosi O; Edmond MB; Street WN; Cromwell JW; Salinas JL
    Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115104. PubMed ID: 32650284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
    Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
    Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and validation of a simple and robust model to predict 30-day mortality in patients with
    Katzer KC; Hagel S; Reuken PA; Bruns T; Stallmach A
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32912845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with
    Stevens VW; Shoemaker HE; Jones MM; Jones BE; Nelson RE; Khader K; Samore MH; Rubin MA
    Infect Control Hosp Epidemiol; 2020 May; 41(5):510-516. PubMed ID: 31996280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin levels associate with severity of Clostridium difficile infection.
    Rao K; Walk ST; Micic D; Chenoweth E; Deng L; Galecki AT; Jain R; Trivedi I; Yu M; Santhosh K; Ring C; Young VB; Huffnagle GB; Aronoff DM
    PLoS One; 2013; 8(3):e58265. PubMed ID: 23505476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection.
    Na X; Martin AJ; Sethi S; Kyne L; Garey KW; Flores SW; Hu M; Shah DN; Shields K; Leffler DA; Kelly CP
    PLoS One; 2015; 10(4):e0123405. PubMed ID: 25906284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors associated with development of severe-complicated Clostridium difficile infection.
    Shivashankar R; Khanna S; Kammer PP; Harmsen WS; Zinsmeister AR; Baddour LM; Pardi DS
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1466-71. PubMed ID: 23702192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Clinical Risk Models for Clostridioides difficile
    Madden GR; Petri WA; Costa DVS; Warren CA; Ma JZ; Sifri CD
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0067622. PubMed ID: 35727061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.